When to combine endocrine therapy with a new agent for hormone receptor-positive metastatic breast cancer in postmenopausal women Journal Article
| Author: | Seidman, A. D. |
| Article Title: | When to combine endocrine therapy with a new agent for hormone receptor-positive metastatic breast cancer in postmenopausal women |
| Abstract: | This landscape of endocrine therapy for metastatic breast cancer is changing rapidly. The recent report that palbociclib improved median PFS when combined with fulvestrant in patients with progression despite prior endocrine therapy is compelling. © 2016, UBM Medica Healthcare Publications. All rights reserved. |
| Journal Title: | Oncology (Norwalk) |
| Volume: | 30 |
| Issue: | 3 |
| ISSN: | 0890-9091 |
| Publisher: | C M P Medica LLC * The Oncology Group |
| Date Published: | 2016-03-01 |
| Start Page: | 224, 226, 228 |
| Language: | English |
| PROVIDER: | scopus |
| PUBMED: | 26984215 |
| DOI/URL: | |
| Notes: | Article -- Export Date: 2 August 2016 -- Source: Scopus |
